<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li S</submitter><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>NHGRI</funding><funding>NHGRI NIH HHS</funding><funding>NIH Common Fund</funding><pagination>841-862</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11080285</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>111(5)</volume><pubmed_abstract>RNA sequencing (RNA-seq) has recently been used in translational research settings to facilitate diagnoses of Mendelian disorders. A significant obstacle for clinical laboratories in adopting RNA-seq is the low or absent expression of a significant number of disease-associated genes/transcripts in clinically accessible samples. As this is especially problematic in neurological diseases, we developed a clinical diagnostic approach that enhanced the detection and evaluation of tissue-specific genes/transcripts through fibroblast-to-neuron cell transdifferentiation. The approach is designed specifically to suit clinical implementation, emphasizing simplicity, cost effectiveness, turnaround time, and reproducibility. For clinical validation, we generated induced neurons (iNeurons) from 71 indi</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>The clinical utility and diagnostic implementation of human subject cell transdifferentiation followed by RNA sequencing.</pubmed_title><pmcid>PMC11080285</pmcid><funding_grant_id>R35 HG011311</funding_grant_id><funding_grant_id>U01 HG007942</funding_grant_id><funding_grant_id>P50 HD103555</funding_grant_id><funding_grant_id>U01 HG007709</funding_grant_id><pubmed_authors>Ketkar S</pubmed_authors><pubmed_authors>Undiagnosed Diseases Network</pubmed_authors><pubmed_authors>Rosenfeld JA</pubmed_authors><pubmed_authors>Nguyen MTT</pubmed_authors><pubmed_authors>Liu P</pubmed_authors><pubmed_authors>Burrage LC</pubmed_authors><pubmed_authors>Bajic A</pubmed_authors><pubmed_authors>Lee B</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Lalani S</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Bacino CA</pubmed_authors><pubmed_authors>Hernandez PP</pubmed_authors><pubmed_authors>Chao HT</pubmed_authors><pubmed_authors>Neeley MB</pubmed_authors><pubmed_authors>Nagamani SC</pubmed_authors><pubmed_authors>Khoramnia A</pubmed_authors><pubmed_authors>Clark GD</pubmed_authors><pubmed_authors>Emrick L</pubmed_authors><pubmed_authors>Craigen WJ</pubmed_authors><pubmed_authors>Worley KC</pubmed_authors><pubmed_authors>Weisz-Hubshman M</pubmed_authors><pubmed_authors>Pena M</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Potocki L</pubmed_authors><pubmed_authors>Machol K</pubmed_authors><pubmed_authors>Sheppard J</pubmed_authors><pubmed_authors>Eng CM</pubmed_authors><pubmed_authors>Sinson JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>The clinical utility and diagnostic implementation of human subject cell transdifferentiation followed by RNA sequencing.</name><description>RNA sequencing (RNA-seq) has recently been used in translational research settings to facilitate diagnoses of Mendelian disorders. A significant obstacle for clinical laboratories in adopting RNA-seq is the low or absent expression of a significant number of disease-associated genes/transcripts in clinically accessible samples. As this is especially problematic in neurological diseases, we developed a clinical diagnostic approach that enhanced the detection and evaluation of tissue-specific genes/transcripts through fibroblast-to-neuron cell transdifferentiation. The approach is designed specifically to suit clinical implementation, emphasizing simplicity, cost effectiveness, turnaround time, and reproducibility. For clinical validation, we generated induced neurons (iNeurons) from 71 indi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-03T00:08:50.659Z</modification><creation>2025-04-06T09:32:56.643Z</creation></dates><accession>S-EPMC11080285</accession><cross_references><pubmed>38593811</pubmed><doi>10.1016/j.ajhg.2024.03.007</doi></cross_references></HashMap>